GORE® EXCLUDER® Endoprosthesis French Mandatory Registry

NCT02308839 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 181

Last updated 2020-05-22

Study results available
· View outcomes & findings →

Summary

This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® Excluder® Endoprosthesis in the treatment of infra-renal Abdominal Aortic Aneurysms (AAA).

Conditions

  • Abdominal Aortic Aneurysm

Interventions

DEVICE

GORE® EXCLUDER® Endoprosthesis

Endovascular therapy to treat abdominal aortic aneurysms

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Principal Investigators

  • Eric Steinmetz, Prof · Centre Hospitalier Universitaire du Bocage

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2018-09-26
Completion
2018-10-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308839 on ClinicalTrials.gov